Broadway Research Bldg, Rm 880, Johns Hopkins University School of Medicine, 722 N. Broadway, Baltimore, MD 21205, United States.
Antiviral Res. 2010 Jan;85(1):295-302. doi: 10.1016/j.antiviral.2009.08.007. Epub 2009 Sep 4.
Elite controllers (EC) are HIV-1 infected patients control viral replication to a level of <50 copies/ml without antiretroviral therapy. These patients are also known as elite suppressors, or HIV controllers, and they differ from traditional long-term non-progressors (LTNPs) who maintain stable CD4 counts and are asymptomatic without antiretroviral therapy. Recent studies suggest that many EC are infected with replication-competent virus. Thus it appears that host factors such as innate immunity, the humoral immune response, and the cellular immune response are involved in the suppression of viral replication in EC. This article will review the effector mechanisms that are thought to play a role in the remarkable control of viral replication seen in these patients. This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, Vol 85, issue 1, 2010.
精英控制器(EC)是指未经抗逆转录病毒治疗就能将病毒复制水平控制在<50 拷贝/ml 的 HIV-1 感染者。这些患者也被称为精英抑制者或 HIV 控制器,与传统的长期非进展者(LTNPs)不同,后者在不接受抗逆转录病毒治疗的情况下能维持稳定的 CD4 计数和无症状状态。最近的研究表明,许多 EC 仍被具有复制能力的病毒感染。因此,宿主因素如先天免疫、体液免疫反应和细胞免疫反应似乎参与了 EC 中病毒复制的抑制。本文将综述被认为在这些患者中对病毒复制的显著控制起作用的效应机制。本文是抗病毒研究杂志第 25 周年特刊的一部分,该特刊专门讨论抗逆转录病毒药物发现和开发,第 85 卷,第 1 期,2010 年。